skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

OPTN/SRTR 2011 Annual Data Report: Kidney

American journal of transplantation, 2013-01, Vol.13, p.11-46 [Peer Reviewed Journal]

Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons ;Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.12019 ;PMID: 23237695

Full text available

Citations Cited by
  • Title:
    OPTN/SRTR 2011 Annual Data Report: Kidney
  • Author: Matas, A. J. ; Smith, J. M. ; Skeans, M. A. ; Lamb, K. E. ; Gustafson, S. K. ; Samana, C. J. ; Stewart, D. E. ; Snyder, J. J. ; Israni, A. K. ; Kasiske, B. L.
  • Subjects: End‐stage renal disease ; Humans ; Immunosuppressive Agents - administration & dosage ; kidney transplant ; Kidney Transplantation ; Mortality ; Pediatrics ; Tissue Donors ; transplant outcomes ; transplant waiting list ; Transplants & implants ; United States ; Waiting Lists
  • Is Part Of: American journal of transplantation, 2013-01, Vol.13, p.11-46
  • Description: ABSTRACT  A shortage of kidneys for transplant remains a major problem for patients with end‐stage renal disease. The number of candidates on the waiting list continues to increase each year, while organ donation numbers remain flat. Thus, transplant rates for adult wait‐listed candidates continue to decrease. However, pretransplant mortality rates also show a decreasing trend. Many kidneys recovered for transplant are discarded, and discard rates are increasing. Living donation rates have been essentially unchanged for the past decade, despite introduction of desensitization, non‐directed donations, and kidney paired donation programs. For both living and deceased donor recipients, early posttransplant results have shown ongoing improvement, driven by decreases in rates of graft failure and return to dialysis. Immunosuppressive drug use has changed little, except for the Food and Drug Administration approval of belatacept in 2011, the first approval of a maintenance immunosuppressive drug in more than a decade. Pediatric kidney transplant candidates receive priority under the Share 35 policy. The number of pediatric transplants peaked in 2005, and decreased to a low of 760 in 2011. Graft survival and short‐term renal function continue to improve for pediatric recipients. Posttransplant lymphoproliferative disorder is an important concern, occurring in about one‐third of pediatric recipients.
  • Publisher: Malden, USA: Blackwell Publishing Inc
  • Language: English
  • Identifier: ISSN: 1600-6135
    EISSN: 1600-6143
    DOI: 10.1111/ajt.12019
    PMID: 23237695
  • Source: Geneva Foundation Free Medical Journals
    MEDLINE
    Alma/SFX Local Collection
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait